Is a
Patent attributes
Current Assignee
0
Patent Jurisdiction
Patent Number
Patent Inventor Names
Susan Kautz0
Daniel Dix0
Kelly Frye0
Date of Patent
February 7, 2012
0Patent Application Number
128350650
Date Filed
July 13, 2010
0Patent Citations Received
0
0
...
Patent Primary Examiner
Patent abstract
Formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the fusion protein has the sequence of SEQ ID NO:4.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
